Are you looking for lead candidate compounds for your target and do you want your drug discovery program to be more efficient, in terms of both time and cost?
Pivot Park Screening Centre (PPSC) is your optimal partner in early drug discovery.
Projects are tailored to your requirements; We provide drug discovery services in the fields of biochemical and cellular assay development, lab automation, Ultra-High-Throughput Screening (uHTS, usually in 1536-well format) and hit-to-lead biological profiling, in order to find novel leads for drug development. All major read-out modalities are available in-house ensuring rapid generation of high-quality hits. As first CRO we integrated Mass Spectrometry (MALDI-TOF MS) into our uHTS system. You can either bring your own compound library or use our 300K IP-free druglike compound library. Our fully automated robot system can handle over 1 mln. compounds per screen. The past 10 years we have successfully completed more than 150 screening campaigns.
We are continuously expanding our early drug discovery know-how, compound library and services to add value to our vibrant client network and the pharmaceutical R&D community.
Through this we help you accelerate drug discovery for a healthier society.
✔ Integrated approach for early drug discovery
✔ Rapid generation of high-quality hits;
All major read-out modalities available in-house including MALDI-TOF MS
✔ Handling of large customer compound libraries;
bring your own library or use our 300k in-house compound library
✔ Big pharma-like uHTS set-up and top-notch read-out technologies
✔ Very experienced screening site for ELF & pharma-accounts
✔ Broad knowledge in different assay development-solutions
✔ From disease targets to high-quality starting points for drug development
✔ Affinity Selection Mass Spectrometry (ASMS)
Interested? Get in touch and we’ll help you accelerate your drug discovery.
PPSC is located at Pivot Park in the Netherlands, which focuses on pharmaceutical R&D. It is an inspiring campus for open innovation in life sciences.
A cellular-based assay – Quite straightforward, right?
At Pivot Park Screening Centre, we develop and carry out many different assay formats (biochemical, cellular, or biophysical assays). Cellular
Pivot Park Screening Centre part of the economic mission: Biomedical Innovation to Boston
Together with more than fifty innovative Dutch companies (startups, SMEs and large companies) and knowledge institutions Pivot Park Screening Centre
We started a program to identify novel hits that inhibit the interaction between the viral spike protein subunit S1 and human angiotensin-converting enzyme 2 (hACE2).
Discovery Europe 2023 in Berlin, June 6-7
Join us at Discovery EU and network with us and over 400 industry leaders. We will be there to discuss the latest advancements in ultra-High Throughput Screening, Mass Spectrometry and ASMS.
Is your assay amendable to ultra-High-Throughput Screening?
Seven aspects to consider…
Subscribe to our newsletter
Pivot Park – Banting Building (RE600)
Kloosterstraat 9
5349 AB Oss
The Netherlands
Pivot Park Screening Centre
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands
To download this publication we would like to receive your e-mail.
To download this publication we would like to receive your e-mail.
To download this publication we would like to receive your e-mail.
